NEWHALL CHARLES W III

SUPN

NEWHALL CHARLES W III serves as Director at Supernus Pharmaceuticals, Inc. (SUPN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$1.38M

Net Position

Net Seller

$1.38M

Companies Traded

SUPN

Active Period

Aug 2025 – Oct 2025

3 total trades

Most Recent

Sell SUPN

Oct 9, 2025 · $1.27M

NEWHALL CHARLES W III's Insider Trading at Supernus Pharmaceuticals, Inc. (SUPN)

Buys

0 · $0.00

Sells

3 · $1.38M

Total Shares Bought

Total Shares Sold

27,412

SUPN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Oct 9, 2025↗	Sell	25,000	$50.77	$1.27M
Aug 25, 2025↗	Sell	1,000	$45.00	$45.0K
Aug 22, 2025↗	Sell	1,412	$45.00	$63.5K

Related Insiders

William Todd Horich

officer: SVP, Commercial Operations

SUPNSell · Mar 10, 2026

Frank Mottola

officer: SVP, Chief Tech. Ops. Officer

SUPNSell · Mar 9, 2026

GEMAYEL GEORGES

director

SUPNSell · Mar 6, 2026

Bethany Sensenig

Director

SUPNSell · Feb 19, 2026

Bethany Sensenig

director

SUPNSell · Feb 19, 2026

Frank Mottola

SVP, Chief Tech. Ops. Officer

SUPNSell · Dec 19, 2025

Padmanabh P. Bhatt

Sr. VP of IP, CSO

SUPNSell · Dec 18, 2025

Jack A. Khattar

President, CEO

SUPNSell · Oct 9, 2025

Explore More Insider Trading Data

SUPN Insider Trading Activity

View all insider trades at Supernus Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity